Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Aug 27:6:283.
doi: 10.3389/fvets.2019.00283. eCollection 2019.

Cytological Grading of Breast Tumors-The Human and Canine Perspective

Affiliations
Review

Cytological Grading of Breast Tumors-The Human and Canine Perspective

Krithiga Kuppusamy et al. Front Vet Sci. .

Abstract

Human breast cancers (HBCs) are one of the leading causes of global cancer death among women. Domesticated canines are the most affected domestic species with a prevalence rate of breast cancer more than three times in women. While the human cancer patients receive substantial diagnostic and treatment facilities, inadequacy in canine cancer care, calls for greater attention. Fine Needle Aspiration Cytology (FNAC) is comparatively simple, quick, and easily reproducible technique, which aids in pre-surgical diagnosis. In humans, FNAC has a standard protocol, the Robinson's grading system, which has high correlation with the established histological grading system of Scarff Bloom- Richardson. However, Canine Mammary Tumors (CMTs), which are known to be similar to HBCs in biological behavior and gene expressions, still bank on the histopathological methods for diagnostic purposes. This review sheds light on various factors that could be considered for developing a standard FNAC technique for CMT grading and analyzes its future perspectives.

Keywords: breast; canine; cytology; grading; human; tumor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Different types of tumors and the cytological parameters currently used in canines for differentiating malignant and benign tumors.
Figure 2
Figure 2
Illustration depicting the appearance of cells that could be considered for different cytological grades in CMT.

Similar articles

Cited by

References

    1. Bansal C, Pujani M, Sharma KL, Srivastava AN, Singh US. Grading systems in the cytological diagnosis of breast cancer: a review. J Cancer Res Ther. (2014) 10:839–45. 10.4103/0973-1482.140979 - DOI - PubMed
    1. Eifel P, Axelson JA, Costa J, Crowley J, Curran W, Deshler A, et al. . National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst. (2001) 93:979–89. 10.1093/oxfordjournals.jncimonographs.a003460 - DOI - PubMed
    1. Howell LP, Gandour-Edwards R, O'Sullivan D. Application of the Scarff-Bloom-Richardson tumor grading system to fine-needle aspirates of the breast. Am J Clin Pathol. (1994) 101:262–5. 10.1093/ajcp/101.3.262 - DOI - PubMed
    1. (1997). The uniform approach to breast fine-needle aspiration biopsy. National Cancer Institute Fine-Needle Aspiration of Breast Workshop Subcommittees. Diagn Cytopathol. 16:295–311. 10.1002/(SICI)1097-0339(1997)16:4<295::AID-DC1>3.0.CO;2-D - DOI - PubMed
    1. Abdelmegeed SM, Mohammed S. Canine mammary tumors as a model for human disease. Oncol Lett. (2018) 15:8195–205. 10.3892/ol.2018.8411 - DOI - PMC - PubMed

LinkOut - more resources